Xyence in a nutshell

A Management Company with an excellent financial and scientific profile

A Management Company with an excellent financial and scientific profile

Xyence is a Management Company providing capital and competences to ambitious projects in the field of Life Sciences.

Our Team draws on deep industry expertise, clinical insights and cross-asset class investing experience to drive advances in Life Sciences to improve the lives of patients with unmet medical needs.

The Biopharma opportunity

Revolution in biology

Number and nature of modalities is expanding rapidly

Recent scientific breakthrough in gene editing, stem cells, immuno-oncology, RNA therapy and others are disrupting how we will treat diseases in the coming years.

Avenues to treat existing diseases and unmet clinical needs have been growing exponentially in the last few decades thanks to new biotech modalities, opening up a variety of investment opportunities.

Terapieorali Terapieiniettabili Anticorpi Vettori Oligonucleotidi Terapiecellulari mRNA Geneediting Microbiota Terapiedigitali Pills Injectables Antibodies Vectors Oligos Cells mRNA Geneediting Microbiome Digitaltherapies Today 2010s 2000s 1990s 1980s

Our Mission

We are a Life Science Company Builder

We are a Life Science Company Builder
We support the development of early stage assets targeting unmet clinical needs
  • 01

    We have a clear investment decision process

    This will focus on capital velocity, time-to-exit and de-risking investment opportunities, always maximizing the potential expected returns.

  • 02

    We invest in european opportunities

    Where science and human capital conditions are ideal for investment, and where entry valuations are more attractive than elsewhere.

  • 03

    Executed by an experienced leadership team

    The team experience, international approach and track record will help cherry pick & develop attractive technologies and assets.

A novel model of innovation to lead your research program to a cure for patients

A novel model of innovation to lead your research program to a cure for patients

Submit your proposal

Our Portfolio

XYence’s Portfolio companies